Metopirone

Metyrapone, the active ingredient in Metopirone, is a steroidogenesis inhibitor presented as an oral tablet for systemic use. It works by blocking cortisol synthesis, making it useful in the medical management of Cushing's syndrome and as a diagnostic agent for evaluating adrenal gland function in patients with suspected endocrine disorders.

GNH USA supplies Metopirone as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality and regulatory compliance across global markets.

Metyrapone is employed in conditions related to excess cortisol production and adrenal function testing.

Cushing's syndrome: reduces cortisol levels in patients with endogenous hypercortisolism. Diagnostic testing of adrenal function: helps evaluate ACTH reserve and adrenal responsiveness during endocrine assessment.

Metyrapone may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Nausea - Dizziness - Headache - Fatigue

Serious or Rare Side Effects: - Adrenal insufficiency - Severe hypertension - Allergic reaction, including rash or anaphylaxis

When prescribing Metopirone, clinicians should consider several safety measures.

Monitor electrolyte levels: watch for hypokalemia and sodium imbalance. Assess cortisol before discontinuation: avoid abrupt withdrawal in dependent patients. Use caution in cardiovascular disease: hypertension may worsen. Avoid in known hypersensitivity: discontinue if allergic signs appear. Adjust dose in hepatic impairment: liver function may affect metabolism. Store at room temperature: keep in the original pack, protect from moisture.

Metyrapone can interact with other medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Ketoconazole: potent CYP3A4 inhibition may increase metyrapone levels. - Rifampin: strong enzyme induction can markedly lower drug exposure. - Phenytoin and other anticonvulsants: accelerate metabolism, reducing effectiveness.

Moderate Interactions (Monitor Closely): - Oral contraceptives: cortisol reduction may affect hormone balance. - Antihypertensives: blood pressure changes may require dose adjustment. - NSAIDs: may increase risk of gastrointestinal irritation.